Is relaxo a good stock to buy?
Is relaxo a good stock to buy?
Every company has risks, and we’ve spotted 1 warning sign for Relaxo Footwears you should know about. Of course Relaxo Footwears may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
How do I buy relaxo shares?
You can easily buy Relaxo Footwears shares in Groww by creating a demat account and getting the KYC documents verified online.
What is CAGR of Relaxo Footwear?
Market Cap ₹ 24,403 Cr….Profit & Loss.
Stock Price CAGR | |
---|---|
5 Years: | 32% |
3 Years: | 33% |
1 Year: | -11% |
Is relaxo a large cap company?
Relaxo Footwears Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 25538.57 Crore) operating in Leather sector.
What is the future of relaxo?
Based on our forecasts, a long-term increase is expected, the “RELAXO” stock price prognosis for 2027-05-24 is 2450.060 INR. With a 5-year investment, the revenue is expected to be around +155.52%. Your current $100 investment may be up to $255.52 in 2027.
Is relaxo overvalued?
The key valuation ratios of Relaxo Footwears Ltd’s currently when compared to its past seem to suggest it is in the Overvalued zone.
Will relaxo share price increase?
Relaxo Footwears Ltd. quote is equal to 983.550 INR at 2022-06-10. Based on our forecasts, a long-term increase is expected, the “RELAXO” stock price prognosis for 2027-06-07 is 2423.890 INR. With a 5-year investment, the revenue is expected to be around +146.44%.
Is Relaxo Footwear a multibagger?
The footwear stock has been a consistent performer and a multibagger.
Is Relaxo overvalued?
Is Relaxo a monopoly?
The Prof explained that the wafer-thin margins that Relaxo makes (Rs. 4.48 per pair) discourages competitors from barging into the field and enables Relaxo to enjoy a virtual monopoly. He also pointed out that the business is a “difficult” one and that this providers an “entry barrier” against pesky intruders.
Is Relaxo footwear a multibagger?
Is relaxo a debt free company?
The company has significantly decreased its debt by 19.16 Cr. Company has been maintaining healthy ROCE of 26.47% over the past 3 years. Company is virtually debt free. Company has a healthy Interest coverage ratio of 21.93.